Detalles de la búsqueda
1.
Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
J Infect Dis
; 226(3): 431-440, 2022 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584386
2.
Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals.
J Gastroenterol Hepatol
; 37(1): 190-199, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374128
3.
Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study.
Aliment Pharmacol Ther
; 56(4): 713-722, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735794
4.
Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study.
Hepatol Int
; 16(2): 282-293, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35075593
5.
Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C.
Cancers (Basel)
; 12(9)2020 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32933027
Resultados
1 -
5
de 5
1
Próxima >
>>